(Q44445674)

3 December 2017

Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase (English)

1 reference

3 December 2017

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(03)01674-1

3 January 2024

author

Johannes-Peter Stasch

4

object named as

Johannes-Peter Stasch

1 reference

3 December 2017

1

Peter Schmidt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12754054

3 January 2024

author name string

Matthias Schramm

2

1 reference

3 December 2017

Henning Schröder

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

16 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12754054

full work available at URL

3 January 2024

https://api.elsevier.com/content/article/PII:S0014299903016741?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(03)01674-1

https://api.elsevier.com/content/article/PII:S0014299903016741?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(03)01674-1

European Journal of Pharmacology

3 January 2024

published in

1 reference

3 December 2017

468

1 reference

3 December 2017

167-174

1 reference

3 December 2017

3

1 reference

Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

On the activation of soluble guanylyl cyclase by nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Interaction of soluble guanylate cyclase with YC-1: kinetic and resonance Raman studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Mechanism of YC-1-induced activation of soluble guanylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Soluble guanylate cyclase: an old therapeutic target re-visited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Dissociation of nitric oxide from soluble guanylate cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Human recombinant soluble guanylyl cyclase: expression, purification, and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Molecular mechanisms and therapeutic strategies related to nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Functional properties of a naturally occurring isoform of soluble guanylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Inhibition of deactivation of NO-sensitive guanylyl cyclase accounts for the sensitizing effect of YC-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Soluble guanylate cyclase is allosterically inhibited by direct interaction with 2-substituted adenine nucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Receptor binding assay for nitric oxide- and heme-independent activators of soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

NO-independent regulatory site on soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

NO-independent stimulators of soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

A molecular basis for nitric oxide sensing by soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Inhibition of soluble guanylate cyclase by ODQ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901674-1

Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase

7 January 2021

24

1 reference

https://api.crossref.org/works/10.1016/S0014-2999(03)01674-1

3 January 2024

Identifiers

1 reference

3 December 2017

1 reference